Key facts
- Recovery from MRONJ jaw surgery depends on disease stage and original prescription reason.
- The specific drug type is less critical for postoperative outcomes.
- The study was published in the Journal of Oral and Maxillofacial Surgery (JOMS).
New research published in the Journal of Oral and Maxillofacial Surgery (JOMS) indicates that postoperative outcomes for medication-related osteonecrosis of the jaw (MRONJ) surgery are closely tied to the disease stage and the underlying reason for the medication's original prescription. The findings suggest that the specific type of medication used is less influential on patient recovery than these other factors. This research provides new insights into the management and treatment planning for patients suffering from MRONJ.